SEALSQ VP Jean-Pierre Enguent sells 35,000 shares
The sale comprised multiple transactions priced from $2.42 to $2.49 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
SEALSQ Corp Vice President, R&DSS Jean-Pierre Enguent reported a sale of 35,000 ordinary shares on October 6, 2026, at a weighted average price of $2.4553 per share under a Rule 10b5-1 trading plan adopted October 13, 2025.
On October 5, 2026, he received an award of 50,000 employee stock options and exercised options covering 35,000 ordinary shares at $0.01 per share. The option exercise was also under the Rule 10b5-1 plan.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Ordinary Shares F1, F2 | 35,000 | $2.4553 | $86K |
| Grant/Award | Employee Stock Option Plan (right to buy) | 50,000 | $0.00 | $0.00 |
| Exercise | Employee Stock Option Plan (right to buy) F3 | 35,000 | $0.00 | $0.00 |
| Exercise | Ordinary Shares | 35,000 | $0.01 | $350.00 |
Footnotes (3)
- F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 13, 2025.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.42 to $2.49, inclusive. The reporting person undertakes to provide to SEALSQ Corp, any security holder of SEALSQ Corp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
- F3. The options exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 13, 2025.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
Employee Stock Option Plan (right to buy) financial
exercise price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many LAES options did Jean-Pierre Enguent exercise, and at what price?
When do Jean-Pierre Enguent's reported LAES options expire?
AI-generated analysis. How Rhea-AI works. Not financial advice.